EichorEICHOR
Location: Cullman Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Cullman

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Cullman Clinical Trials · Eli Lilly and Company · NCT07369011Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Particip
Phase 3 · North Central Neurology Associates- Site Number : 8401100 · Sanofi · NCT07325292Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06568367A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · Cullman Clinical Trials · Eli Lilly and Company · NCT07282600A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Phase 3 · Alkermes Investigational Site · Alkermes, Inc. · NCT07455383A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemi
Phase 2 · Cullman Clinical Trials · Regeneron Pharmaceuticals · NCT07477704Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Wh
Phase 3 · Kailera Clinical Site · Kailera · NCT07284875A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Phase 2 · Alkermes Investigator Site · Alkermes, Inc. · NCT06843590A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Phase 2/Phase 3 · Alkermes Investigational Site · Alkermes, Inc. · NCT06767683A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are Hi
Phase 3 · Cullman Clinical Trials ( Site 3813) · Merck Sharp & Dohme LLC · NCT06667700A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06878261A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Phase 3 · Alkermes Investigational Site · Alkermes, Inc. · NCT07502443Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Phase 2 · Cullman Clinical Trials · Vertex Pharmaceuticals Incorporated · NCT06619860Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabete
Phase 3 · Kailera Clinical Site · Kailera · NCT07284901A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insuli
Phase 3 · Cullman Clinical Trials · Novo Nordisk A/S · NCT07076199
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.